The angiotensin-converting enzyme inhibitor captopril inhibits poly(adp-ribose) polymerase activation and exerts beneficial effects in an ovine model of burn and smoke injury

Shock

Volumn 36, Issue 4, 2011, Pages 402-409

  Asmussen, Sven ^a   Bartha, Eva ^a   Olah, Gabor ^a   Sbrana, Elena ^a   Rehberg, Sebastian W ^a   Yamamoto, Yusuke ^a   Enkhbaatar, Perenlei ^a   Hawkins, Hal K ^a   Ito, Hiroshi ^a   Cox, Robert A ^a   Traber, Lillian D ^a   Traber, Daniel L ^a   Szabo, Csaba ^a  

^a University of Texas Medical Branch School of Medicine   (United States)

Author keywords

angiotensin; burn injury; cell death; lung; nitric oxide; nitrosative stress; oxidative stress; Smoke injury; vascular dysfunction

Indexed keywords

CAPTOPRIL; NICOTINAMIDE ADENINE DINUCLEOTIDE ADENOSINE DIPHOSPHATE RIBOSYLTRANSFERASE; TRANSFORMING GROWTH FACTOR BETA;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; ARTIFICIAL VENTILATION; BURN; CONTROLLED STUDY; ENZYME ACTIVATION; FEMALE; FLUID RESUSCITATION; HEMODYNAMICS; IMMUNOHISTOCHEMISTRY; LEUKOCYTE; LUNG BURN; LUNG DISEASE; LUNG FUNCTION; NONHUMAN; OXIDATIVE STRESS; SMOKE; TRACHEOSTOMY; WESTERN BLOTTING;

ANGIOTENSIN-CONVERTING ENZYME INHIBITORS; ANIMALS; BLOTTING, WESTERN; BURNS; CAPTOPRIL; ENZYME ACTIVATION; FEMALE; HEART; IMMUNOHISTOCHEMISTRY; LEUKOCYTES; LUNG; NITRIC OXIDE; POLY(ADP-RIBOSE) POLYMERASES; RESPIRATION, ARTIFICIAL; SHEEP, DOMESTIC;

EID: 80052962099     PISSN: 10732322     EISSN: 15400514     Source Type: Journal    
DOI: 10.1097/SHK.0b013e318228f614     Document Type: Article

References (28)

1. Herndon D (ed.): Total Burn Care. Philadelphia, PA: Saunders, 2007.
2. Enkhbaatar P, Traber DL: Pathophysiology of acute lung injury in combined burn and smoke inhalation injury. Clin Sci (Lond) 107(2):137-143, 2004. (Pubitemid 39070929)
3. Latha B, Babu M: The involvement of free radicals in burn injury: a review. Burns 27(4):309-317, 2001. (Pubitemid 32451669)
4. Traber DL, Traber MG, Enkhbaatar P, Herndon DN: Tocopherol as treatment for lung injury associated with burn and smoke inhalation. J Burn Care Res 30(1):164-165, 2009.
5. Jagtap P, Szabo C: Poly(ADP-ribose) polymerase and the therapeutic effects of its inhibitors. Nat Rev Drug Discov 4(5):421-440, 2005. (Pubitemid 40704125)
6. Pacher P, Szabo C: Role of the peroxynitrite-poly(ADP-ribose) polymerase pathway in human disease. Am J Pathol 173(1):2-13, 2008. (Pubitemid 351947950)
7. Avlan D, Unlü A, Ayaz L, Camdeviren H, Nayci A, Aksöyek S: Poly(ADPribose) synthetase inhibition reduces oxidative and nitrosative organ damage after thermal injury. Pediatr Surg Int 21(6):449-455, 2005. (Pubitemid 40931914)
8. Liaudet L, Pacher P, Mabley JG, Virág L, Soriano FG, Haskó G, Szabo C: Activation of poly(ADP-Ribose) polymerase-1 is a central mechanism of lipopolysaccharide-induced acute lung inflammation. Am J Respir Crit Care Med 165(3):372-377, 2002. (Pubitemid 34118511)
9. Shimoda K, Murakami K, Enkhbaatar P, Traber LD, Cox RA, Hawkins HK, Schmalstieg FC, Komjati K, Mabley JG, Szabo C, et al.: Effect of PARP inhibition on burn and smoke inhalation injury in sheep. Am J Physiol Lung Cell Mol Physiol 285(1):L240-L249, 2003. (Pubitemid 36736487)
10. Murthy KG, Xiao CY, Mabley JG, Chen M, Szabo C: Activation of poly(ADPribose) polymerase in circulating leukocytes during myocardial infarction. Shock 21(3):230-234, 2004.
11. Tóth-Zsámboki E, Horváth E, Vargova K, Pankotai E, Murthy K, Zsengellér Z, Bárány T, Pék T, Fekete K, Kiss RG, et al.: Activation of poly(ADP-ribose) polymerase by myocardial ischemia and coronary reperfusion in human circulating leukocytes. Mol Med 12(9-10):221-228, 2006. (Pubitemid 44925021)
12. Mabley JG, Horváth EM, Murthy KG, Zsengellér Z, Vaslin A, Benko R, Kollai M, Szabo C: Gender differences in the endotoxin-induced inflammatory and vascular responses: potential role of poly(ADP-ribose) polymerase activation. J Pharmacol Exp Ther 315(2):812-820, 2005. (Pubitemid 41500748)
13. Horváth EM, Benko R, Gero D, Kiss L, Szabo C: Treatment with insulin inhibits poly(ADP-ribose)polymerase activation in a rat model of endotoxemia. Life Sci 82(3-4):205-209, 2008.
14. Bartha E, Asmussen S, Olah G, Rehberg SW, Yamamoto Y, Traber DL, Szabo C: Burn and smoke injury activates poly(ADP-ribose)polymerase in circulating leukocytes. Shock 36:144-148, 2011.
15. Paul M, Poyan Mehr A, Kreutz R: Physiology of local renin-angiotensin systems. Physiol Rev 86(3):747-803 2006. (Pubitemid 44033382)
16. Traber DL, Schlag G, Redl H, Traber LD: Pulmonary edema and compliance changes following smoke inhalation. J Burn Care Rehabil 6:490-494, 1985. (Pubitemid 16233818)
17. Ushio-Fukai M: Redox signaling in angiogenesis: role of NADPH oxidase. Cardiovasc Res 71(2):226-235, 2006.
18. Ohtsu H, Frank HD, Utsunomiya H, Eguchi S: Redox-dependent protein kinase regulation by angiotensin II: mechanistic insights and its pathophysiology. Antioxid Redox Signal 7(9-10):1315-1326, 2005. (Pubitemid 41232529)
19. Förstermann U. Nitric oxide and oxidative stress in vascular disease. Pflugers Arch 459(6):923-939, 2010.
20. Szabó C, Pacher P, Zsengellér Z, Vaslin A, Komjáti K, Benkö R, Chen M, Mabley JG, Kollai M: Angiotensin IIYmediated endothelial dysfunction: role of poly(ADP-ribose) polymerase activation. Mol Med 10(1-6):28-35, 2004; (Pubitemid 39440318)
21. Pillai JB, Gupta M, Rajamohan SB, Lang R, Raman J, Gupta MP: Poly(ADP-ribose) polymerase-1Ydeficient mice are protected from angiotensin IIYinduced cardiac hypertrophy. Am J Physiol Heart Circ Physiol 291(4): H1545-H1553, 2006. (Pubitemid 44497657)
22. Wynn TA: Cellular and molecular mechanisms of fibrosis. J Pathol 214(2): 199-210, 2008. (Pubitemid 351160157)
23. Gabriel VA: Transforming growth factor-" and angiotensin in fibrosis and burn injuries. J Burn Care Res. 30(3):471-481, 2009.
24. Brizio-Molteni L, Piano G, Warpeha RL, Solliday NH, Molteni A, Angelats J, Lewis N, Patejak-Radwanski H: Angiotensin-1-converting enzyme activity as index of pulmonary damage in thermal injury with or without smoke inhalation. Ann Clin Lab Sci 22:1-10, 1992.
25. Jiang JS, Wang LF, Chou HC, Chen CM: Angiotensin-converting enzyme inhibitor captopril attenuates ventilator-induced lung injury in rats. J Appl Physiol 102(6):2098-2103, 2007.
26. Chen CM, Chou HC, Wang LF, Lang YD: Captopril decreases plasminogen activator inhibitor-1 in rats with ventilator-induced lung injury. Crit Care Med 36(6):1880-1885, 2008.
27. Lange M, Enkhbaatar P, Nakano Y, Traber DL: Role of nitric oxide in shock: the large animal perspective. Front Biosci 14:1979-1989, 2010.
28. Rehberg S, Maybauer MO, Maybauer DM, Traber LD, Enkhbaatar P, Traber DL: The role of nitric oxide and reactive nitrogen species in experimental ARDS. Front Biosci (Schol Ed) 2:18-29, 2010.